USNA Chief Commercial Officer Brent Neidig Sells $32K of Stock
Brent Neidig sold 1,602 shares of USNA on June 12, 2026, for $32,280.
Reviewed by automated data checks against the source filing. How we make and check alerts
Brent Neidig, CHIEF COMMERCIAL OFFICER at USANA Health Sciences, Inc. ($USNA), sold 1,602 shares at an average price of $20.15, worth about $32,280.30, on June 12, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $USNA is down 5.1% after 1 week, up 10.7% after 1 month and down 21.9% to date (from the $19.91 close on Jun 12, 2026).
USNA
USANA Health Sciences, Inc.
Key Points
- Brent Neidig, Chief Commercial Officer of USNA, sold 1,602 shares worth $32,280 on June 12, 2026.
- Shares of USNA traded at $19.41 with institutional investors like BlackRock making significant adjustments to their holdings.
- Analyst firm D.A. Davidson has maintained a 'hold' rating on USNA, with recent price targets ranging from $36 to $62.
Get $USNA trade alerts by text
We text you when insiders, Congress or big funds trade $USNA. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated USANA Health Sciences, Inc. alert may contain errors. Disclosures
Brent Neidig, the Chief Commercial Officer of USNA, sold 1,602 shares of the company on June 12, 2026. The transaction was valued at $32,280, with an average selling price of $20.15 per share. This sale was not part of a pre-planned trading program.
Insider Buying and Selling at USANA Health Sciences, Inc.
Brent Neidig has been active in selling USNA shares, having sold 909 shares on June 15, 2026, at an average price of $20.01. Other insiders have also sold shares recently, including Paul Jones, the Chief People Officer, who sold 5,561 shares on June 8, 2026, at $18.50 per share.
Other Institutional Activity in USNA
Institutional investors have been adjusting their stakes in USNA. BlackRock, Inc. increased its holdings by 78,415 shares, bringing its total to 1,190,416 shares worth about $20.8 million. Pzena Investment Management LLC reduced its position by 25,496 shares, ending with 1,108,933 shares valued at approximately $19.4 million. Renaissance Technologies LLC also reduced its stake by 129,693 shares, holding 1,017,630 shares valued at $17.8 million. Meanwhile, Nantahala Capital Management, LLC significantly increased its holdings by 225,000 shares, resulting in a total of 810,074 shares worth about $14.2 million.
USANA Health Sciences, Inc. Stock Up 37.3%
Shares of USNA are trading at approximately $19.41. The stock has experienced various institutional movements, reflecting differing investment strategies among major shareholders.
Analysts Set New Price Targets
D.A. Davidson has maintained a 'hold' rating on USNA, with recent price targets ranging from $36 to $62. The firm's most recent target, set on February 27, 2025, is $36.
Bottom Line
Brent Neidig's recent sale of USNA shares comes amid notable institutional changes in the company's ownership. While insiders and large funds adjust their positions, analysts like D.A. Davidson continue to hold a steady outlook on the stock. Investors watch these moves closely, though it's important to remember that such filings are reported after the fact and may not reflect the current state of holdings.
Related Filing Alerts
Source: Brent Neidig's Form 4 filing on $USNA (Jun 12, 2026). Find the original filing: USNA Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts